Trial Details
NO_LONGER_AVAILABLEBasic Information
| Clinical ID | c2150 |
|---|---|
| Identifier | NCT03914261 |
| Trial Title | Expanded Access to Risankizumab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Ulcerative Colitis (UC) |
| Interventions | DRUG: Risankizumab |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | NULL |
| Country/Region | NULL |
Enrollment Criteria
| Sex Requirement | NULL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | EXPANDED_ACCESS |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |